Suzhou Basecare Gains Approval for Innovative Analyzer
Company Announcements

Suzhou Basecare Gains Approval for Innovative Analyzer

Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.

Suzhou Basecare Medical Corp. Ltd. has received approval from the Jiangsu Medical Products Administration for its innovative sperm quality analyzer, BKA210. This cutting-edge device, which operates without staining sperm, enhances diagnostic accuracy and efficiency, marking a significant advancement in the field of semen analysis.

For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App